Back to Journals » Therapeutics and Clinical Risk Management » Volume 12

Therapeutics and Clinical Risk Management


Archive: Volume 12, 2016

Impact of preoperative chronic renal failure on liver transplantation: a population-based cohort study

Chung PC, Chen HP, Lin JR, Liu FC, Yu HP

Therapeutics and Clinical Risk Management 2016, 12:1855-1860

Published Date: 14 December 2016

Kinetics of circulating endothelial progenitor cells in patients undergoing carotid artery surgery

Kalender G, Kornberger A, Lisy M, Beiras-Fernandez A, Stock UA

Therapeutics and Clinical Risk Management 2016, 12:1841-1847

Published Date: 14 December 2016

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis

Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K

Therapeutics and Clinical Risk Management 2016, 12:1831-1840

Published Date: 5 December 2016

Complete blood cell count components and coronary slow-flow phenomenon

Arjmand N, Dehghani MR

Therapeutics and Clinical Risk Management 2016, 12:1827-1829

Published Date: 2 December 2016

Preoperative risk factors in total thyroidectomy of substernal goiter

Bove A, Di Renzo RM, D'Urbano G, Bellobono M, D'Addetta V, Lapergola A, Bongarzoni G

Therapeutics and Clinical Risk Management 2016, 12:1805-1809

Published Date: 28 November 2016

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients

Huang JY, Hsu CW, Yang CW, Hung CC, Huang WH

Therapeutics and Clinical Risk Management 2016, 12:1797-1803

Published Date: 28 November 2016

Health behaviors of patients diagnosed with type 2 diabetes mellitus and their influence on the patients’ satisfaction with life

Rosiek A, Kornatowski T, Frąckowiak-Maciejewska N, Rosiek-Kryszewska A, Wyżgowski P, Leksowski K

Therapeutics and Clinical Risk Management 2016, 12:1783-1792

Published Date: 25 November 2016

Balanced discussion of second-generation antihistamines' data

Boev R, Bentz JWG

Therapeutics and Clinical Risk Management 2016, 12:1777-1781

Published Date: 24 November 2016

Thyroid dysfunction among type 2 diabetic female Egyptian subjects

Elebrashy IN, El Meligi A, Rashed L, Salam RF, Youseef E, Fathy SA

Therapeutics and Clinical Risk Management 2016, 12:1757-1762

Published Date: 21 November 2016

Pharmaceutical interventions in the management of tuberculosis in a pneumophtisiology department, Ivory Coast

Abrogoua DP, Kamenan BAT, Ahui BJM, Doffou E

Therapeutics and Clinical Risk Management 2016, 12:1749-1756

Published Date: 22 November 2016

Intestinal permeability in a patient with liver cirrhosis

Aguirre Valadez JM, Rivera-Espinosa L, Méndez-Guerrero O, Chávez-Pacheco JL, García Juárez I, Torre A

Therapeutics and Clinical Risk Management 2016, 12:1729-1748

Published Date: 18 November 2016

Protective effect of tartary buckwheat on renal function in type 2 diabetics: a randomized controlled trial

Qiu J, Li ZG, Qin YC, Yue YF, Liu YP

Therapeutics and Clinical Risk Management 2016, 12:1721-1727

Published Date: 18 November 2016

The effect of body mass index on perioperative thermoregulation

Özer AB, Yildiz Altun A, Erhan ÖL, Çatak T, Karatepe Ü, Demirel İ, Çağlar Toprak G

Therapeutics and Clinical Risk Management 2016, 12:1717-1720

Published Date: 18 November 2016

Treatment cost of narcolepsy with cataplexy in Central Europe

Maresova P, Novotny M, Klímová B, Kuča K

Therapeutics and Clinical Risk Management 2016, 12:1709-1715

Published Date: 18 November 2016

Predictive value of serum uric acid in hospitalized adolescents and adults with acute asthma

Abdulnaby NK, Sayed AO, Shalaby NM

Therapeutics and Clinical Risk Management 2016, 12:1701-1708

Published Date: 14 November 2016

Effectiveness of etofenamate for treatment of knee osteoarthritis: a randomized controlled trial

Güner S, Gökalp MA, Gözen A, Ünsal SŞ, Güner Şİ

Therapeutics and Clinical Risk Management 2016, 12:1693-1699

Published Date: 14 November 2016

Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases

Gori E, Mduluza T, Nyagura M, Stray-Pedersen B, Gomo ZA

Therapeutics and Clinical Risk Management 2016, 12:1659-1666

Published Date: 11 November 2016

Antiallergic effect of the atomized extract of rhizome of Curcuma longa, flowers of Cordia lutea and leaves of Annona muricata

Arroyo-Acevedo J, Franco-Quino C, Ruiz-Ramírez E, Chávez-Asmat R, Anampa-Guzmán A, Raéz-González E, Cabanillas-Coral J

Therapeutics and Clinical Risk Management 2016, 12:1643-1647

Published Date: 10 November 2016

Management of extrapulmonary sarcoidosis: challenges and solutions

Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ

Therapeutics and Clinical Risk Management 2016, 12:1623-1634

Published Date: 7 November 2016

Shear wave elastography imaging for assessing the chronic pathologic changes in advanced diabetic kidney disease

Hassan K, Loberant N, Abbas N, Fadi H, Shadia H, Khazim K

Therapeutics and Clinical Risk Management 2016, 12:1615-1622

Published Date: 7 November 2016

Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure

Feng JQ, Kong XQ, Sheng YH, Yang R

Therapeutics and Clinical Risk Management 2016, 12:1609-1613

Published Date: 3 November 2016

Laparoscopic total extraperitoneal repair under spinal anesthesia versus general anesthesia: a randomized prospective study

Donmez T, Erdem VM, Sunamak O, Erdem DA, Avaroglu HI

Therapeutics and Clinical Risk Management 2016, 12:1599-1608

Published Date: 27 October 2016

Costs of inguinal hernia repair associated with using different medical devices in the Czech Republic

Marešová P, Peteja M, Lerch M, Zonca P, Kuca K

Therapeutics and Clinical Risk Management 2016, 12:1593-1597

Published Date: 26 October 2016

Secukinumab for ankylosing spondylitis and psoriatic arthritis

Lubrano E, Perrotta FM

Therapeutics and Clinical Risk Management 2016, 12:1587-1592

Published Date: 21 October 2016

Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients

Głażewska EK, Niczyporuk M, Ławicki S, Szmitkowski M, Zajkowska M, Będkowska GE, Przylipiak A

Therapeutics and Clinical Risk Management 2016, 12:1579-1585

Published Date: 21 October 2016

The potential role for use of mitochondrial DNA copy number as predictive biomarker in presbycusis

Falah M, Houshmand M, Najafi M, Balali M, Mahmoudian S, Asghari A, Emamdjomeh H, Farhadi M

Therapeutics and Clinical Risk Management 2016, 12:1573-1578

Published Date: 19 October 2016

High-frequency oscillatory ventilation is an effective treatment for severe pediatric acute respiratory distress syndrome with refractory hypoxemia

Guo YX, Wang ZN, Li YT, Pan L, Yang LF, Hu Y, Sun YY, Cai LM, Chen ZG

Therapeutics and Clinical Risk Management 2016, 12:1563-1571

Published Date: 19 October 2016

The use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics

Benfante A, Basile M, Battaglia S, Spatafora M, Scichilone N

Therapeutics and Clinical Risk Management 2016, 12:1553-1562

Published Date: 14 October 2016

Comparison of classical diagnostic criteria and Chinese revised diagnostic criteria for fever of unknown origin in Chinese patients

Li JJ, Huang WX, Shi ZY, Sun Q, Xin XJ, Zhao JQ, Yin Z

Therapeutics and Clinical Risk Management 2016, 12:1545-1551

Published Date: 12 October 2016

Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database

Lee J, Noh Y, Shin S, Lim H, Park RW, Bae SK, Oh E, Kim GJ, Kim JH, Lee S

Therapeutics and Clinical Risk Management 2016, 12:1533-1543

Published Date: 11 October 2016

Association of medications for lifestyle-related diseases with reflux esophagitis

Asaoka D, Nagahara A, Hojo M, Matsumoto K, Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, Shimada Y, Osada T, Watanabe S

Therapeutics and Clinical Risk Management 2016, 12:1507-1515

Published Date: 4 October 2016

Cataract induction by administration of nitroglycerin in cardiac patients through imbalance in redox status

El-Gharabawy RM, Ahmed AS, Al-Najjar AH

Therapeutics and Clinical Risk Management 2016, 12:1487-1496

Published Date: 27 September 2016

The effects of magnesium sulfate therapy after severe diffuse axonal injury

Zhao L, Wang W, Zhong J, Li YY, Cheng YZ, Su Z, Zheng W, Guan XD

Therapeutics and Clinical Risk Management 2016, 12:1481-1486

Published Date: 27 September 2016

Is there any superiority among diagnostic methods in organizing pneumonia in terms of clinical features of the patients?

Kavakli K, Ocal N, Dogan D, Cicek AF, Isik H, Gurkok S

Therapeutics and Clinical Risk Management 2016, 12:1473-1479

Published Date: 26 September 2016

Combined treatment in punctate inner choroidopathy

Terelak-Borys B, Zagajewska K, Jankowska-Lech I, Tesla P, Grabska-Liberek I

Therapeutics and Clinical Risk Management 2016, 12:1467-1471

Published Date: 23 September 2016

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis

Liu C, Mao Z, Yang MM, Kang HJ, Liu H, Pan L, Hu J, Luo J, Zhou FH

Therapeutics and Clinical Risk Management 2016, 12:1455-1466

Published Date: 22 September 2016

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients

Zaid AN, Ghanem M, Shweiki D, Shtewi H, Shaheen R, Al Helaly S, Khayyat Z, Al Ramahi R, Zyoud SH

Therapeutics and Clinical Risk Management 2016, 12:1425-1432

Published Date: 19 September 2016

Association of low serum aluminum level with mortality in hemodialysis patients

Hsu CW, Weng CH, Lee CC, Lin-Tan DT, Chen KH, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2016, 12:1417-1424

Published Date: 14 September 2016

Clinical prediction rules for failed nonoperative reduction of intussusception

Khorana J, Patumanond J, Ukarapol N, Laohapensang M, Visrutaratna P, Singhavejsakul J

Therapeutics and Clinical Risk Management 2016, 12:1411-1416

Published Date: 13 September 2016

Reporting of adverse events related to dietary supplements to a public health center by medical staff: a survey of clinics and pharmacies

Ide K, Yamada H, Kawasaki Y, Noguchi M, Kitagawa M, Chiba T, Kagawa Y, Umegaki K

Therapeutics and Clinical Risk Management 2016, 12:1403-1410

Published Date: 12 September 2016

Patients’ safety: is there a systemic release of gentamicin by gentamicin-coated tibia nails in clinical use?

Moghaddam A, Graeser V, Westhauser F, Dapunt U, Kamradt T, Woerner SM, Schmidmaier G

Therapeutics and Clinical Risk Management 2016, 12:1387-1393

Published Date: 7 September 2016

Retargeting the management of hypercholesterolemia – focus on evolocumab

Colletti A, Derosa G, Cicero AFG

Therapeutics and Clinical Risk Management 2016, 12:1365-1376

Published Date: 6 September 2016

Clinical analysis of contributors to the delayed gallbladder opacification following the use of water-soluble contrast medium

Ku MC, Kok VC, Lee MY, Hsu SM, Lee PY, Chang CW, Tyan YS, Juan CW

Therapeutics and Clinical Risk Management 2016, 12:1357-1364

Published Date: 6 September 2016

Safety of long-term use of linezolid: results of an open-label study

Vazquez JA, Arnold AC, Swanson RN, Biswas P, Bassetti M

Therapeutics and Clinical Risk Management 2016, 12:1347-1354

Published Date: 1 September 2016

Does surgical treatment within 4 hours after trauma have an influence on neurological remission in patients with acute spinal cord injury?

Biglari B, Child C, Yildirim TM, Swing T, Reitzel T, Moghaddam A

Therapeutics and Clinical Risk Management 2016, 12:1339-1346

Published Date: 31 August 2016

Rituximab use in adult primary glomerulopathy: where is the evidence?

Mallat SG, Itani HS, Abou-Mrad RM, Abou Arkoub R, Tanios BY

Therapeutics and Clinical Risk Management 2016, 12:1317-1327

Published Date: 29 August 2016

Surgical versus conservative treatment following acute rupture of the Achilles tendon: is there a pedobarographic difference?

Karaaslan F, Mermerkaya MU, Çıraklı A, Karaoğlu S, Duygulu F

Therapeutics and Clinical Risk Management 2016, 12:1311-1315

Published Date: 29 August 2016

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults

Lee KJ, Chow V, Weissman A, Tulpule S, Aldoss I, Akhtari M

Therapeutics and Clinical Risk Management 2016, 12:1301-1310

Published Date: 25 August 2016

Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia

Wudneh F, Assefa A, Nega D, Mohammed H, Solomon H, Kebede T, Woyessa A, Assefa Y, Kebede A, Kassa M

Therapeutics and Clinical Risk Management 2016, 12:1293-1300

Published Date: 24 August 2016

How does hospitalization affect continuity of drug therapy: an exploratory study

Blozik E, Signorell A, Reich O

Therapeutics and Clinical Risk Management 2016, 12:1277-1283

Published Date: 22 August 2016

Vojta method in the treatment of developmental hip dysplasia – a case report

Kiebzak W, Żurawski A, Dwornik M

Therapeutics and Clinical Risk Management 2016, 12:1271-1276

Published Date: 19 August 2016

Clinical management of a challenging malignancy, osteoblastoma-like osteosarcoma: a report of four cases and a review of the literature

Ozger H, Alpan B, Söylemez MS, Ozkan K, Salduz A, Bilgic B, Sirin BK

Therapeutics and Clinical Risk Management 2016, 12:1261-1270

Published Date: 17 August 2016

Prognostic indicators for failed nonsurgical reduction of intussusception

Khorana J, Singhavejsakul J, Ukarapol N, Laohapensang M, Siriwongmongkol J, Patumanond J

Therapeutics and Clinical Risk Management 2016, 12:1231-1237

Published Date: 9 August 2016

Role of isavuconazole in the treatment of invasive fungal infections

Wilson DT, Dimondi VP, Johnson SW, Jones TM, Drew RH

Therapeutics and Clinical Risk Management 2016, 12:1197-1206

Published Date: 3 August 2016

Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study

Wang A, Li Z, Yang Y, Chen G, Wang C, Wu Y, Ruan C, Liu Y, Wang Y, Wu S

Therapeutics and Clinical Risk Management 2016, 12:1191-1196

Published Date: 2 August 2016

Effect of biological factors on successful measurements with skeletal-muscle 1H-MRS

Isobe T, Okamoto Y, Hirano Y, Ando H, Takada K, Sato E, Shinoda K, Tadano K, Takei H, Kamizawa S, Mori Y, Suzuki H

Therapeutics and Clinical Risk Management 2016, 12:1133-1137

Published Date: 20 July 2016

Is there a relationship between fracture healing and mean platelet volume?

Serbest S, Tiftikci U, Tosun HB, Gumustas SA, Uludag A

Therapeutics and Clinical Risk Management 2016, 12:1095-1099

Published Date: 13 July 2016

Correlation between obesity and chronic kidney disease: is obstructive sleep apnea an interfering factor?

Santos-Camilo M, Arães SP, Hirotsu C, Tufik S, Andersen ML

Therapeutics and Clinical Risk Management 2016, 12:1093-1094

Published Date: 11 July 2016

Relationship between the iceA gene of Helicobacter pylori and clinical outcomes

Huang XJ, Deng ZM, Zhang Q, Li WY, Wang BN, Li MY

Therapeutics and Clinical Risk Management 2016, 12:1085-1092

Published Date: 6 July 2016

Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum]

Sechi A, Dardis A, Bembi B

Therapeutics and Clinical Risk Management 2016, 12:1083-1084

Published Date: 7 July 2016

Role of biologics in severe eosinophilic asthma – focus on reslizumab

Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R

Therapeutics and Clinical Risk Management 2016, 12:1075-1082

Published Date: 1 July 2016

Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China

Zeng R, Shou T, Yang KX, Shen T, Zhang JP, Zuo RX, Zheng YQ, Yan XM

Therapeutics and Clinical Risk Management 2016, 12:1065-1074

Published Date: 30 June 2016

Atrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patients

Ong CT, Wong YS, Wu CS, Su YH

Therapeutics and Clinical Risk Management 2016, 12:1057-1064

Published Date: 29 June 2016

The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study

Yang Y, Wang A, Zhao X, Wang C, Liu L, Zheng H, Wang Y, Cao Y, Wang Y

Therapeutics and Clinical Risk Management 2016, 12:1049-1056

Published Date: 29 June 2016

True anteroposterior view pedicle screw insertion technique

Bai JY, Zhang W, An JL, Sun YP, Ding WY, Shen Y

Therapeutics and Clinical Risk Management 2016, 12:1039-1047

Published Date: 29 June 2016

Syncope as a presentation of acute pulmonary embolism

Altınsoy B, Erboy F, Tanrıverdi H, Uygur F, Örnek T, Atalay F, Tor M

Therapeutics and Clinical Risk Management 2016, 12:1023-1028

Published Date: 27 June 2016

New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim

Ghidini M, Hahne JC, Trevisani F, Panni S, Ratti M, Toppo L, Tomasello G

Therapeutics and Clinical Risk Management 2016, 12:1009-1015

Published Date: 24 June 2016

Value of cyst localization to predict cystobiliary communication in patients undergoing conservative surgery with hydatid cyst

Alan B, Kapan M, Teke M, Hattapoğlu S, Arıkanoğlu Z

Therapeutics and Clinical Risk Management 2016, 12:995-1001

Published Date: 15 June 2016

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?

Fonseca Lima EJ, Lima DEP, Serra GHC, Abreu e Lima MAZS, Mello MJG

Therapeutics and Clinical Risk Management 2016, 12:983-988

Published Date: 14 June 2016

Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review

Zhang Y, Luo L, Wang X, Liu X, Wang X, Ding Y

Therapeutics and Clinical Risk Management 2016, 12:975-981

Published Date: 14 June 2016

Pazopanib in the management of advanced soft tissue sarcomas

Cranmer LD, Loggers ET, Pollack SM

Therapeutics and Clinical Risk Management 2016, 12:941-955

Published Date: 9 June 2016

A case of gait disturbance caused by low-dose gabapentin

Kanao-Kanda M, Kanda H, Takahata O, Kunisawa T

Therapeutics and Clinical Risk Management 2016, 12:927-929

Published Date: 9 June 2016

Clinical usefulness of mepolizumab in severe eosinophilic asthma

Menzella F, Lusuardi M, Montanari G, Galeone C, Facciolongo N, Zucchi L

Therapeutics and Clinical Risk Management 2016, 12:907-916

Published Date: 8 June 2016

Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies

Bonsu KO, Owusu IK, Buabeng KO, Reidpath DD, Kadirvelu A

Therapeutics and Clinical Risk Management 2016, 12:887-906

Published Date: 3 June 2016

Herpetic esophagitis following bendamustine-containing regimen

Yamane H, Monobe Y, Tanikawa T, Ochi N, Honda Y, Kawamoto H, Takigawa N

Therapeutics and Clinical Risk Management 2016, 12:883-886

Published Date: 2 June 2016

Growth hormone therapy for Prader–Willi syndrome: challenges and solutions

Grugni G, Sartorio A, Crinò A

Therapeutics and Clinical Risk Management 2016, 12:873-881

Published Date: 2 June 2016

The potential utilizations of hydrogen as a promising therapeutic strategy against ocular diseases

Tao Y, Geng L, Xu WW, Qin LM, Peng GH, Huang YF

Therapeutics and Clinical Risk Management 2016, 12:799-806

Published Date: 19 May 2016

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J

Therapeutics and Clinical Risk Management 2016, 12:771-775

Published Date: 13 May 2016

Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis

Song ZW, Shao C, Feng C, Lu YL, Gao Y, Dong CY

Therapeutics and Clinical Risk Management 2016, 12:763-769

Published Date: 12 May 2016

The effect of interferon gamma on conventional fractionated radiation-induced damage and fibrosis in the pelvic tissue of rabbits

Yang Y, Liu Z, Wang J, Chai Y, Su J, Shi F, Wang J, Che SM

Therapeutics and Clinical Risk Management 2016, 12:755-762

Published Date: 11 May 2016

Recovery of a 10-year-old girl from methicillin-resistant Staphylococcus aureus sepsis in response to low-dose ceftaroline treatment

Borgmann S, Rieß B, Wernitz-Keibel T, Bühler M, Layer F, Strommenger B

Therapeutics and Clinical Risk Management 2016, 12:749-753

Published Date: 11 May 2016

Diagnosis and screening of patients with hereditary angioedema in primary care

Henao MP, Kraschnewski JL, Kelbel T, Craig TJ

Therapeutics and Clinical Risk Management 2016, 12:701-711

Published Date: 2 May 2016

High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma

Lv W, Yan T, Wang G, Zhao W, Zhang T, Zhou D

Therapeutics and Clinical Risk Management 2016, 12:687-691

Published Date: 2 May 2016

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism

Tellor KB, Van Tuyl JS, Armbruster AL

Therapeutics and Clinical Risk Management 2016, 12:667-674

Published Date: 26 April 2016

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?

Tural Onur S, Sokucu SN, Dalar L, Iliaz S, Kara K, Buyukkale S, Altin S

Therapeutics and Clinical Risk Management 2016, 12:651-656

Published Date: 22 April 2016

Absorbable scaphoid screw development: a comparative study on biomechanics

Wang Y, Song MG, Xu YQ, He XQ, Zhu YL

Therapeutics and Clinical Risk Management 2016, 12:643-650

Published Date: 22 April 2016

Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase

Guerrero-Orriach JL, Ariza-Villanueva D, Florez-Vela A, Garrido-Sánchez L, Moreno-Cortés MI, Galán-Ortega M, Ramírez-Fernández A, Alcaide Torres J, Santiago Fernandez C, Navarro Arce I, Melero-Tejedor JM, Rubio-Navarro M, Cruz-Mañas J

Therapeutics and Clinical Risk Management 2016, 12:623-630

Published Date: 21 April 2016

Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum?

Avci D, Karagoz H, Ozer O, Esmeray K, Bulut K, Aykas F, Cetinkaya A, Uslu E, Karahan S, Basak M, Erden A

Therapeutics and Clinical Risk Management 2016, 12:617-622

Published Date: 19 April 2016

The application of nutrition support in conservative treatment of chylous ascites after abdominal surgery

Pan W, Cai SY, Luo HL, Ouyang SR, Zhang WD, Wei ZR, Wang DL

Therapeutics and Clinical Risk Management 2016, 12:607-612

Published Date: 15 April 2016

The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus

Bužga M, Maresova P, Seidlerová A, Zonča P, Holéczy P, Kuča K

Therapeutics and Clinical Risk Management 2016, 12:599-605

Published Date: 15 April 2016

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

Wang XY, Lim-Jurado M, Prepageran N, Tantilipikorn P, Wang DY

Therapeutics and Clinical Risk Management 2016, 12:585-597

Published Date: 13 April 2016

Application of surgical navigation in styloidectomy for treating Eagle’s syndrome

Dou G, Zhang Y, Zong CL, Chen YL, Guo YX, Tian L

Therapeutics and Clinical Risk Management 2016, 12:575-583

Published Date: 12 April 2016

Dysplasia epiphysealis hemimelica (Trevor disease) in the ankle

Ozan F, Doğar F, Gürbüz K, Ekinci Y, Bilal Ö, Öncel ES

Therapeutics and Clinical Risk Management 2016, 12:545-547

Published Date: 6 April 2016

Management of children’s acute diarrhea by community pharmacies in five towns of Ethiopia: simulated client case study

Abegaz TM, Belachew SA, Abebe TB, Gebresilassie BM, Teni FS, Woldie HG

Therapeutics and Clinical Risk Management 2016, 12:515-526

Published Date: 5 April 2016

Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases

Czarnywojtek A, Płazińska MT, Zgorzalewicz-Stachowiak M, Woliński K, Stangierski A, Miechowicz I, Waligórska-Stachura J, Gut P, Królicki L, Zioncheck M, Ruchała M

Therapeutics and Clinical Risk Management 2016, 12:505-513

Published Date: 4 April 2016

Correlation of visceral adiposity index with chronic kidney disease in the People’s Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity

Xu XM, Zhao Y, Zhao ZH, Zhu SS, Liu XY, Zhou CM, Shao XF, Liang Y, Duan CY, Holthöfer H, Zou HQ

Therapeutics and Clinical Risk Management 2016, 12:489-494

Published Date: 29 March 2016

Guidelines for acute management of hyperammonemia in the Middle East region

Alfadhel M, Al Mutairi F, Makhseed N, Al Jasmi F, Al-Thihli K, Al-Jishi E, AlSayed M, Al-Hassnan ZN, Al-Murshedi F, Häberle J, Ben-Omran T

Therapeutics and Clinical Risk Management 2016, 12:479-487

Published Date: 31 March 2016

The impact of oxidized serum albumin on the oncotic pressure and hydration status of peritoneal dialysis patients

Hassan K, Kristal B, Hassan F, Abo Saleh S, Michelis R

Therapeutics and Clinical Risk Management 2016, 12:463-469

Published Date: 24 March 2016

Post-stroke bacteriuria among stroke patients attending a physiotherapy clinic in Ghana: a cross-sectional study

Donkor ES, Akumwena A, Amoo PK, Owolabi MO, Aspelund T, Gudnason V

Therapeutics and Clinical Risk Management 2016, 12:457-462

Published Date: 17 March 2016

Development and novel therapeutics in hepatocellular carcinoma: a review

Ingle PV, Samsudin SZ, Chan PQ, Ng MK, Heng LX, Yap SC, Chai ASH, Wong ASY

Therapeutics and Clinical Risk Management 2016, 12:445-455

Published Date: 16 March 2016

Prevalence of diabetes and determinants: evidence from a minority region in People’s Republic of China

Chen Q, Yi Y, Xia N, Li C, Luo Z, Huang G, Chen Y, Li S, Lai L, Wang M, Tan J, Zhang J, Shen H, Li B, Su F, Wei H, Dai X, Lu F, Li S

Therapeutics and Clinical Risk Management 2016, 12:427-433

Published Date: 14 March 2016

Concentrated insulins: the new basal insulins

Lamos EM, Younk LM, Davis SN

Therapeutics and Clinical Risk Management 2016, 12:389-400

Published Date: 9 March 2016

Allergic diseases among children: nutritional prevention and intervention

Hendaus MA, Jomha FA, Ehlayel M

Therapeutics and Clinical Risk Management 2016, 12:361-372

Published Date: 7 March 2016

Evaluation of safety and efficacy of zonisamide in adult patients with partial, generalized, and combined seizures: an open labeled, noncomparative, observational Indian study

Dash A, Ravat S, Srinivasan AV, Shetty A, Kumar V, Achtani R, Mathur VN, Maramattom BV, Bajpai V, Manjunath NC, Narayana RV, Mehta S

Therapeutics and Clinical Risk Management 2016, 12:327-334

Published Date: 29 February 2016

Clinical utility of nivolumab in the treatment of advanced melanoma

Asmar R, Yang J, Carvajal RD

Therapeutics and Clinical Risk Management 2016, 12:313-325

Published Date: 26 February 2016

Ethyl pyruvate protects against sepsis by regulating energy metabolism

Kang H, Mao Z, Zhao Y, Yin T, Song Q, Pan L, Hu X, Hu J, Zhou F

Therapeutics and Clinical Risk Management 2016, 12:287-294

Published Date: 23 February 2016

Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects

Cicero AF, Morbini M, Parini A, Urso R, Rosticci M, Grandi E, Borghi C

Therapeutics and Clinical Risk Management 2016, 12:281-286

Published Date: 23 February 2016

Is ketamine a lifesaving agent in childhood acute severe asthma?

Hendaus MA, Jomha FA, Alhammadi AH

Therapeutics and Clinical Risk Management 2016, 12:273-279

Published Date: 22 February 2016

Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan

Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q

Therapeutics and Clinical Risk Management 2016, 12:233-239

Published Date: 17 February 2016

Influence of MDR1 methylation on the curative effect of interventional embolism chemotherapy for cervical cancer

Huang Z, Zhang S, Shen YP, Liu WX, Long JP, Zhou S

Therapeutics and Clinical Risk Management 2016, 12:217-223

Published Date: 15 February 2016

New combinations in the treatment of COPD: rationale for aclidinium–formoterol

Incorvaia C, Montagni M, Makri E, Ridolo E

Therapeutics and Clinical Risk Management 2016, 12:209-215

Published Date: 15 February 2016

IgG4-related disease: current challenges and future prospects

Lang D, Zwerina J, Pieringer H

Therapeutics and Clinical Risk Management 2016, 12:189-199

Published Date: 15 February 2016

Low-back pain at the emergency department: still not being managed?

Rizzardo A, Miceli L, Bednarova R, Guadagnin GM, Sbrojavacca R, Della Rocca G

Therapeutics and Clinical Risk Management 2016, 12:183-187

Published Date: 12 February 2016

Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery

Tsilimbaris MK, Tsika C, Kymionis GD

Therapeutics and Clinical Risk Management 2016, 12:177-182

Published Date: 12 February 2016

A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar

AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M

Therapeutics and Clinical Risk Management 2016, 12:155-160

Published Date: 9 February 2016

Effect of a nonsurgical treatment program on the gait pattern of idiopathic toe walking: a case report

Szopa A, Domagalska˗Szopa M, Gallert˗Kopyto W, Kiebzak W, Plinta R

Therapeutics and Clinical Risk Management 2016, 12:139-146

Published Date: 10 February 2016

Nutritional management in an elderly man with esophageal and gastric necrosis after caustic soda ingestion: a case report

Rondanelli M, Peroni G, Miccono A, Guerriero F, Guido D, Perna S

Therapeutics and Clinical Risk Management 2016, 12:129-133

Published Date: 4 February 2016

Association of nuclear and mitochondrial genes with audiological examinations in Iranian patients with nonaminoglycoside antibiotics-induced hearing loss

Balali M, Kamalidehghan B, Farhadi M, Ahmadipour F, Ashkezari MD, Hemami MR, Arabzadeh H, Falah M, Meng GY, Houshmand M

Therapeutics and Clinical Risk Management 2016, 12:117-128

Published Date: 28 January 2016

A new modified technique of laparoscopic needle catheter jejunostomy: a 2-year follow-up study

Ye P, Zeng LP, Sun FH, An Z, Li ZB, Hu J

Therapeutics and Clinical Risk Management 2016, 12:103-108

Published Date: 25 January 2016

Risk factors associated with postoperative pain after ophthalmic surgery: a prospective study

Lesin M, Dzaja Lozo M, Duplancic-Sundov Z, Dzaja I, Davidovic N, Banozic A, Puljak L

Therapeutics and Clinical Risk Management 2016, 12:93-102

Published Date: 22 January 2016

Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study

Gregori G, Righi O, Risso P, Boiardi G, Demuru G, Ferzetti A, Galli A, Ghisoni M, Lenzini S, Marenghi C, Mura C, Sacchetti R, Suzzani L

Therapeutics and Clinical Risk Management 2016, 12:87-92

Published Date: 19 January 2016

The value of trabectedin in the treatment of soft tissue sarcoma

Nakamura T, Matsumine A, Sudo A

Therapeutics and Clinical Risk Management 2016, 12:73-79

Published Date: 13 January 2016

Comparison of three approaches of Bernese periacetabular osteotomy

Luo DZ, Zhang H, Zhang WJ

Therapeutics and Clinical Risk Management 2016, 12:67-72

Published Date: 12 January 2016

Video-assisted thoracic surgery reduces early postoperative stress. A single-institutional prospective randomized study

Asteriou C, Lazopoulos A, Rallis T, Gogakos AS, Paliouras D, Tsakiridis K, Zissimopoulos A, Tsavlis D, Porpodis K, Hohenforst-Schmidt W, Kioumis I, Organtzis J, Zarogoulidis K, Zarogoulidis P, Barbetakis N

Therapeutics and Clinical Risk Management 2016, 12:59-65

Published Date: 12 January 2016

Profile of eliglustat tartrate in the management of Gaucher disease

Sechi A, Dardis A, Bembi B

Therapeutics and Clinical Risk Management 2016, 12:53-58

Published Date: 11 January 2016

Particulate matter is associated with sputum culture conversion in patients with culture-positive tuberculosis

Chen KY, Chuang KJ, Liu HC, Lee KY, Feng PH, Su CL, Lin CL, Lee CN, Chuang HC

Therapeutics and Clinical Risk Management 2016, 12:41-46

Published Date: 6 January 2016

Coexistence of squamous cell tracheal papilloma and carcinoma treated with chemotherapy and radiotherapy: a case report

Paliouras D, Gogakos A, Rallis T, Chatzinikolaou F, Asteriou C, Tagarakis G, Organtzis J, Tsakiridis K, Tsavlis D, Zissimopoulos A, Kioumis I, Hohenforst-Schmidt W, Zarogoulidis K, Zarogoulidis P, Barbetakis N

Therapeutics and Clinical Risk Management 2016, 12:1-4

Published Date: 21 December 2015